First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
Clinical trial NCT05964361 · COMPLETED
Trial details
- NCT number
- NCT05964361
- Sponsor
- University Hospital, Antwerp
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-06
- Primary completion
- 2025-09-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.